AMANDA WESSEL: Open Payments
NPI 1417197690 · PLAINFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 37 payments from 11 companies in 2025. Trend: 2023 $90 · 2024 $679 · 2025 $985
Food & beverage: $874Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $322 |
| Teva Pharmaceuticals USA, Inc. | 2 | $129 |
| Vanda Pharmaceuticals Inc. | 5 | $119 |
| E.R. Squibb & Sons, L.L.C. | 5 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| Alkermes, Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 1 | $49 |
| Lundbeck LLC | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: REXULTI, FANAPT, COBENFY, ABILIFY ASIMTUFII, CAPLYTA, ABILIFY MAINTENA, Auvelity, ARISTADA.
Industry payments across IL — which companies pay providers there.
